Pfizer, Direct Buyers Duel For Quick Wins In Celebrex Suit
Pfizer and a proposed class of direct purchasers who allege the drugmaker used fraudulent patents to delay generic-drug competition for its Celebrex painkiller filed dueling motions for summary judgment in Virginia...To view the full article, register now.
Already a subscriber? Click here to view full article